- Home
- BHC vs LIVN Comparison
BHC vs LIVN Comparison
Compare BHC & LIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHC
- LIVN
- Stock Information
- Founded
- BHC N/A
- LIVN 1987
- Country
- BHC Canada
- LIVN United Kingdom
- Employees
- BHC N/A
- LIVN N/A
- Industry
- BHC Biotechnology: Pharmaceutical Preparations
- LIVN Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- BHC Health Care
- LIVN Health Care
- Exchange
- BHC Nasdaq
- LIVN Nasdaq
- Market Cap
- BHC 2.0B
- LIVN 2.1B
- IPO Year
- BHC N/A
- LIVN 1993
- Fundamental
- Price
- BHC $4.59
- LIVN $44.06
- Analyst Decision
- BHC Hold
- LIVN Buy
- Analyst Count
- BHC 5
- LIVN 7
- Target Price
- BHC $7.20
- LIVN $58.57
- AVG Volume (30 Days)
- BHC 2.6M
- LIVN 882.2K
- Earning Date
- BHC 04-30-2025
- LIVN 05-07-2025
- Dividend Yield
- BHC N/A
- LIVN N/A
- EPS Growth
- BHC N/A
- LIVN N/A
- EPS
- BHC N/A
- LIVN N/A
- Revenue
- BHC $9,731,000,000.00
- LIVN $1,275,380,000.00
- Revenue This Year
- BHC $4.92
- LIVN $5.79
- Revenue Next Year
- BHC $2.36
- LIVN $5.51
- P/E Ratio
- BHC N/A
- LIVN N/A
- Revenue Growth
- BHC 8.53
- LIVN 7.62
- 52 Week Low
- BHC $3.96
- LIVN $32.48
- 52 Week High
- BHC $9.85
- LIVN $64.48
- Technical
- Relative Strength Index (RSI)
- BHC 34.85
- LIVN 70.16
- Support Level
- BHC $4.63
- LIVN $35.00
- Resistance Level
- BHC $4.86
- LIVN $37.95
- Average True Range (ATR)
- BHC 0.25
- LIVN 1.30
- MACD
- BHC -0.00
- LIVN 1.06
- Stochastic Oscillator
- BHC 6.02
- LIVN 91.36
About BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.
About LIVN LivaNova PLC
UK-based Livanova was born of a combination between Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, Livanova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.